Robert J. Schott Insider Profile
4 Followers
Robert J. Schott, SVP, Head of Development at Sangamo Therapeutics, holds 75.54K shares in Sangamo Therapeutics (Ticker: SGMOQ).
Robert J. Schott's Trading History
| SGMOQSangamo Therapeutics | Mar 01, 2022 | SVP, Head of Development | Uninformative Buy | ― | $8.84K | |
SGMOQ Insider Shares: 75.54K (0.00%) Robert J. Schott has not reported any informative transactions for SGMOQ, therefore, performance cannot be measured. | ||||||
You May Also Like
Robert J. Schott insider profile FAQ
What stocks does Robert J. Schott hold?
Robert J. Schott holds: SGMOQ stocks.
What is Robert J. Schott's role in Sangamo Therapeutics?
Robert J. Schott's role in Sangamo Therapeutics is SVP, Head of Development.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
